Therapeutic Efficacy of a Melatonin Agonist, Ramelteon, and a Benzodiazepine, Triazolam, in a Mouse Genetic Model of Advanced Sleep Phase Syndrome

Citation

Wisor, J. P. (2009, January). THERAPEUTIC EFFICACY OF A MELATONIN AGONIST, RAMELTEON, AND A BENZODIAZEPINE, TRIAZOLAM, IN A MOUSE GENETIC MODEL OF ADVANCED SLEEP PHASE SYNDROME. In SLEEP (Vol. 32, pp. A60-A61). ONE WESTBROOK CORPORATE CTR, STE 920, WESTCHESTER, IL 60154 USA: AMER ACAD SLEEP MEDICINE.


Read more from SRI

  • A photo of Mary Wagner

    Recognizing the life and work of Mary Wagner 

    A cherished SRI colleague and globally respected leader in education research, Mary Wagner leaves behind an extraordinary legacy of groundbreaking work supporting children and youth with disabilities and their families.

  • Testing XRGo in a robotics laboratory

    Robots in the cleanroom

    A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.

  • SRI research aims to make generative AI more trustworthy

    Researchers have developed a new framework that reduces generative AI hallucinations by up to 32%.